Cornerstone Capital, Inc. Ligand Pharmaceuticals Inc Transaction History

Cornerstone Capital, Inc.

$970 Million
Q1 2024

A detailed history of Cornerstone Capital, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 6,497 shares of LGND stock, worth $659,120. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,497

Previous 6,957 6.61%

Holding current value

$659,120

Previous $496,000 4.44%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$68.64 - $89.2 $31,574 - $41,032	-460 Reduced 6.61%	6,497 $474,000
Q4 2023 Feb 02, 2024	SELL	$49.57 - $72.63 $27,114 - $39,728	-547 Reduced 7.29%	6,957 $496,000
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $207,304 - $255,943	-3,522 Reduced 31.94%	7,504 $449,000
Q2 2023 Aug 21, 2023	SELL	$69.53 - $79.33 $173,060 - $197,452	-2,489 Reduced 18.42%	11,026 $794,000
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $10,178 - $11,947	-155 Reduced 1.13%	13,515 $994,000

Q4 2022 Feb 13, 2023	SELL	$61.72 - $96.74 $109,553 - $171,713	-1,775 Reduced 11.49%	13,670 $913,000
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $125,861 - $200,817	1,325 Added 9.38%	15,445 $1.74 Million
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $82,104 - $106,641	-643 Reduced 4.36%	14,120 $2.18 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $976,490 - $2.12 Million	-9,812 Reduced 39.93%	14,763 $2.25 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $1.22 Million - $1.61 Million	15,160 Added 161.02%	24,575 $2.44 Million
Q3 2020 Oct 27, 2020	BUY	$89.56 - $126.72 $9,045 - $12,798	101 Added 1.08%	9,415 $897,000
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $62,544 - $113,263	-916 Reduced 8.95%	9,314 $1.04 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $41,127 - $70,014	-649 Reduced 5.97%	10,230 $744,000
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $5,913 - $6,928	-61 Reduced 0.56%	10,879 $1.14 Million
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $10,522 - $14,659	-122 Reduced 1.1%	10,940 $1.09 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $884,918 - $1.07 Million	-8,241 Reduced 42.69%	11,062 $1.26 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $4.72 Million - $6.35 Million	-44,570 Reduced 69.78%	19,303 $2.43 Million
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $86,899 - $184,232	677 Added 1.07%	63,873 $8.67 Million
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $1.43 Million - $1.86 Million	-6,780 Reduced 9.69%	63,196 $17.3 Million
Q2 2018 Aug 13, 2018	SELL	$150.77 - $207.98 $809,333 - $1.12 Million	-5,368 Reduced 7.12%	69,976 $14.5 Million
Q1 2018 May 08, 2018	SELL	$138.63 - $182.62 $103,972 - $136,965	-750 Reduced 0.99%	75,344 $12.4 Million
Q4 2017 Feb 12, 2018	BUY	$128.36 - $147.04 $600,853 - $688,294	4,681 Added 6.55%	76,094 $10.4 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $8.63 Million - $9.85 Million	71,413	71,413 $9.72 Million

Others Institutions Holding LGND

# of Institutions

237

Shares Held

16.5M

Call Options Held

77.9K

Put Options Held

25K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.71B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Ligand Pharmaceuticals Inc Transaction History